Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Invasive aspergillosis: treatment].

P Saballs-Radresa1, J L López-Colomés, J Gimeno-Cobos

  • 1Hospital del Mar, Passeig Marítim 25-29, 08003 Barcelona, España. 12822@imas.imim.es

Revista Iberoamericana De Micologia
|March 15, 2005
PubMed
Summary

Invasive aspergillosis is a serious fungal infection primarily impacting immunocompromised patients. Early diagnosis and prompt treatment with available or emerging antifungal therapies, alongside potential surgical intervention, are crucial for patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).

Open forum infectious diseases·2022
Same author

Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy.

Revista clinica espanola·2019
Same author

Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART.

The Journal of antimicrobial chemotherapy·2019
Same author

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Current HIV research·2019
Same author

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.

HIV clinical trials·2017

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Pharmacology

Context:

  • Invasive aspergillosis poses a significant threat to immunocompromised individuals, including those with congenital or acquired immunodeficiencies, neutropenia, organ transplants, or undergoing chemotherapy and corticosteroid therapy.
  • Current treatment options for invasive aspergillosis are limited, necessitating a thorough understanding of available antifungals.

Purpose:

  • To provide a comprehensive overview of current and emerging therapeutic strategies for invasive aspergillosis.
  • To emphasize the importance of understanding patient-specific factors, drug pharmacokinetics, and evidence-based treatment criteria.

Summary:

  • The review details existing treatments such as amphotericin B deoxycholate, lipid formulations, and itraconazole, and anticipates the future roles of voriconazole, posaconazole, liposomal nystatin, and echinocandins.

Related Experiment Videos

  • It highlights the critical need for high clinical suspicion, rapid initiation of antifungal therapy, and consideration of adjuvant treatments, including surgery for specific manifestations like pulmonary aspergillosis and sinusitis.
  • Impact:

    • This information is vital for clinicians managing invasive aspergillosis, enabling informed treatment decisions and improved patient management.
    • Optimizing antifungal therapy and surgical interventions can lead to better clinical outcomes and reduced mortality in this vulnerable patient population.